ArticleFrontiers in global women's health2026
Three-dimensional assessment of macromastia: linking breast morphology to quality of life.
Article in Frontiers in global women's health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Macromastia is associated with substantial physical and psychosocial burden, yet existing diagnostic thresholds, particularly for gigantomastia, are largely derived from weight-based criteria established in Western populations. These standards may be suboptimal for preoperative assessment in Asian women, where breast composition and body habitus differ. Methods: In this cross-sectional study, adult women with breast volumes > 400 mL were recruited from a tertiary plastic surgery center. Preoperative breast morphology was assessed using the VECTRA® XT 3D imaging system, including breast volume, breast width, SNN distance, and ptosis grade. QoL was evaluated using the BREAST-Q Reduction/Mastopexy Module (version 2.0). Associations among morphological parameters, BMI and BREAST-Q domains were comprehensively analyzed. Results: A total of 145 patients underwent 3D imaging and 168 completed the BREAST-Q questionnaire. Fifty-three patients completed both assessments and were included in analyses integrating breast morphology and patient-reported outcomes. Breast volume was positively correlated with BMI and ptosis severity ( Conclusions: Three-dimensional imaging combined with BREAST-Q assessment provides complementary information on the anatomical and patient-reported burden of macromastia. Breast volumes of 1,000 mL or greater were associated with increased ptosis severity and poorer physical well-being and may represent a clinically relevant threshold warranting further investigation. These findings support a multidimensional approach to preoperative evaluation that incorporates breast morphology, body habitus, and patient-reported outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.